Evolving Castration Resistance and Prostate Specific Membrane Antigen Expression: Implications for Patient Management.

Kessel, Katharina; Bernemann, Christof; Bögemann, Martin; Rahbar, Kambiz

Kessel, Katharina; Bernemann, Christof; Bögemann, Martin; Rahbar, Kambiz.

Afiliación

Kessel K; Department of Nuclear Medicine, University Hospital Münster (UKM), 48149 Münster, Germany.
Bernemann C; Translational Tumor Biology Section, Department of Urology and Pediatric Urology, University Hospital Münster (UKM), 48149 Münster, Germany.
Bögemann M; Department of Urology and Pediatric Urology, University Hospital Münster (UKM), 48149 Münster, Germany.
Rahbar K; Network Partner Site Westdeutsches Tumorzentrum (WTZ), 45147 Essen, Germany.

Cancers (Basel) ; 13(14)2021 Jul 16.

Article en En | MEDLINE | ID: mdl-34298770

Palabras clave

177Lu-PSMA-RLT; PSMA; mCRPC; metastatic castration-resistant prostate cancer; prostate-specific membrane antigen; theranostics

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Cancers (Basel) Año: 2021 Tipo del documento: Article País de afiliación: Alemania

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google